| | | |
 |
MC26-001-CG FDA request removal suicidal ideation and behavior warning from label glucagon-like peptide-1.pdf
| 2/6/2026 8:55:15 AM | 402.2 KB |
|
MC26-002-CG FDA - Abbott Initiates Medical Device Correction for FreeStyle Libre 3 and Libre 3 Plus Sensors.pdf
| 2/6/2026 10:46:16 AM | 373.74 KB |
|
MC26-003-CG FDA - Trividia initiate labeling correction for all TRUE METRIX Blood Glucose Monitoring.pdf
| 2/13/2026 12:50:45 PM | 362.1 KB |
|
MC26-004-CG FDA update labeling of capecitabine and fluorouracil (5-FU) risk associate DPD deficiency.pdf
| 2/13/2026 1:47:27 PM | 371.09 KB |
|
MC26-005-CG FDA Warning about Vitamin B6 Deficiency and Associated Seizures for Drug Products.pdf
| 3/27/2026 4:11:24 PM | 360.98 KB |
|
MC26-006-CG FDA – CDRH Early Alert Insulin Pump Issue from Insulet - Affected devices Omnipod 5 Pods.pdf
| 3/30/2026 10:41:54 AM | 448.22 KB |
|
MC26-007-CG FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan).pdf
| 4/8/2026 8:29:38 AM | 401.54 KB |
|
MC26-008-ADAP - Hoja de Localizacion de Entrega.pdf
| 4/17/2026 11:46:10 AM | 1.76 MB |
 |
Thumbs.db
| 4/17/2026 11:47:12 AM | 27 KB |
